El Massachussets Institute of Technology (MIT) homenajeó al Dr. Saul Hertz en un evento que fue grabado y se puede ver aquí.
Agenda:
Barbara Hertz, M.ED.
Curator saulhertzmd.com:
«The Birth of Radionuclides in Medicine at MIT/MGH«
Robert Langer, ScD
MIT Institute Professor
Co-founder of Moderna:
«Carrying the Legacy Forward«
Ilya Gipp, MD, PhD
GE HealthCare, Chief Medical Officer-Oncology:
“Beyond the Half-Life: Linking a Discovery of the Past to the Future of Cancer Care”
David Gilmore, Ed.D.
President, 2027-2028, SNMMI-TS,
Massachusetts College of Pharmacy & Health Sciences, Associate Professor, Nuclear Medicine
«Theranostics: Building a Critical Workforce»
Annick Van Den Abbeele, MD
FACR
Dana Farber Chair Emeritus
Department of Imaging Founding Director, Center for Biomedical Imaging in Oncology:
«TME. Targeting Theranostics: Characterizing the interplay between the TME co-conspirators for more effective therapy”
Julie Price, PhD
MGH Department of Radiology
Director of PET Pharmacokinetic Modeling, Martinos Center
Professor of Radiology, Harvard Medical School
«The Importance of Nuclear Medicine Imaging in Aging and Neurodegeneration«
Jason Dearling, PhD
Head of Radiopharmacology, Mariana Oncology/Novartis:
«Targeting Radioligand Therapy for the treatment of Small Cell Lung Cancer(SCLC) and Beyond«
Sherly Mosessian, PhD
Chief Scientific Officer, SOFIE:
«Probing Potential: «How to Find Success Leveraging Academic-Biotech Partnerships«
Panel Discussion and Questions
Moderator: Alex Brown, MBA. CEO, Convergent Therapeutics